Chinese healthcare is reshaping the healthcare industry with tactics that include negotiating pharmaceutical discounts of up to 70%.
The Chinese government’s bulk buying pharmaceutical program today has cut prescription prices by 52%. The government aims to double the size of the market in the next ten years while closely managing the costs. In addition to revising their pharmaceutical program, billions are being invested into public hospitals and other healthcare programs.